Evidence map›Paper›PMID 32121589›Full record

ArticleJournal of personalized medicine2020

Virtual Reality Treatment for Public Speaking Anxiety in Students. Advancements and Results in Personalized Medicine.

Francisco-Javier Hinojo-Lucena, Inmaculada Aznar-Díaz, María-Pilar Cáceres-Reche, Juan-Manuel Trujillo-Torres, José-María Romero-Rodríguez

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francisco-Javier Hinojo-LucenaDepartment of Didactics and School Organization, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-9507-4058
Inmaculada Aznar-DíazDepartment of Didactics and School Organization, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-0018-1150
María-Pilar Cáceres-RecheDepartment of Didactics and School Organization, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-6323-8054
Juan-Manuel Trujillo-TorresDepartment of Didactics and School Organization, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-2761-3523
José-María Romero-RodríguezDepartment of Didactics and School Organization, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-9284-8919

Funding

Ministerio de Educación, Cultura y Deporte FPU16/01762
6 · The paper itself

Abstract

Public speaking anxiety (PSA) is a common phobia in the student population. Traditionally, exposure therapy has been used as a treatment. However, the use of virtual reality (VR) is increasingly common to treat PSA. The purpose of this paper was to analyze the published scientific literature on VR as a treatment for PSA in students. The articles indexed in two databases (Web of Science and Scopus) were analyzed, with a time period from the beginning of the first publications until 2019 included. The systematic literature review was based on fixed inclusion and exclusion criteria. A total of 13 studies were identified which included 481 students. The results collected indicate that the duration of treatments to have positive effects was at least one week, where the number of sessions was between one and twelve. Furthermore, most VR treatments reported positive effects. Finally, this study showed evidence that VR treatment for PSA is effective while being less invasive than in vivo exposure.

Indexed as

anxiety disordersInternet-based interventionspersonalized medicinepublic speaking anxietyvirtual reality

Identifiers

PMID32121589
PMCPMC7151627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.